# Mark Schiffman

Source: https://onco.cc/people/mark-schiffman/  
OnCo record `mark-schiffman` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

NCI epidemiologist whose HPV natural history studies underpin HPV-based cervical screening and risk-based management worldwide.

## Summary

Mark Schiffman led the Guanacaste and Portland Kaiser cohorts that defined the natural history of HPV infection and cervical precancer, work that established HPV testing as a screening test, single-dose vaccine efficacy signals, and the risk-based ASCCP management guidelines. He leads NCI efforts on automated visual evaluation with AI and self-sampling to bring screening to low-resource settings.

## Fields

- Kind: Person
- Last checked: 2026-09-10
- Tags: hpv; screening; epidemiology
- Role: Senior Investigator, Division of Cancer Epidemiology and Genetics, National Cancer Institute
- Specialisms: HPV natural history; Cervical screening; Risk-based management; Global cervical cancer prevention

## Sources

- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Schiffman%20M%5BAuthor%5D%20HPV%20cervical

## Connected records

- cancers: [Cervical cancer](https://onco.cc/cancers/cervical/)
- technologies: [AI in radiology](https://onco.cc/technologies/radiology-ai-screening/), [HPV & HBV vaccination](https://onco.cc/technologies/hpv-vaccine/)
- institutions: [National Cancer Institute (NIH)](https://onco.cc/institutions/nci/)
- key papers: [Self-collected HPV samples are as accurate as clinician samples and reach women who never attend screening](https://onco.cc/key-papers/paper-hpv-self-sampling-bmj-2018/)

---
JSON: https://onco.cc/api/v1/entities/mark-schiffman.json